Healthline
October 15, 2025
Share on PinterestDermatologists warn that applying baking soda to your skin may come with risks like irritation and sensitivity. Getty Images/J_art Baking soda is growing in […]
October 14, 2025
Share on PinterestA new report ranks U.S states according to residents’ reported mental health and the care available in each state. Lucy Lambriex/Getty Images Nearly 1 […]
October 13, 2025
Share on PinterestThree early onset breast cancer survivors share their stories. From left: Natalia Socorro, Danielle Lindner, and Stephanie Rico Masterson.Design by Viviana Quevedo; Photography courtesy […]
October 11, 2025
Share on PinterestThe FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty […]
Medscape
July 8, 2025
Obesity often brings about, or exacerbates, depression and anxiety. Yet some of the most effective drugs for managing depression are also known to cause weight gain. […]
July 8, 2025
Despite dramatic treatment advances in recent years, the dermatology community has lacked a unified definition for what remission means in plaque psoriasis. Now, a multistage Delphi […]
July 8, 2025
Could a simple advisory or alert in the electronic medical record (EMR) be the key to more frequent diagnosis and effective treatment of high blood pressure […]
July 8, 2025
In young children, the long-term effects of SARS-CoV-2 infection may differ significantly from those in older children or adults. A recent study in JAMA Pediatrics systematically […]
FDA
October 14, 2025
Delivery Method: Certified Mail Reference #: 320-25-97 Product: Drugs Over-the-Counter Drugs Recipient: Recipient Name Dr. Sayed Ibrahim Recipient Title President and Chief Executive Officer Health and […]
October 10, 2025
Generic drug user fees make it possible for FDA and industry to continue to ensure that the American public has access to safe, effective and high-quality […]
October 10, 2025
In September 2022, the FDA User Fee Reauthorization Act of 2022 (FDAUFRA) was enacted, which included the third reauthorization of the Generic Drug User Fee Amendments […]
October 8, 2025
On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc.) for the adjuvant treatment of adults with cutaneous squamous cell carcinoma […]
